The generic medicine industry of India is unlikely to be impacted by United States president Donald Trump's decision to slash drug prices in the US drastically, said Sudarshan Jain, Secretary General ...

we’ll be in a state where we’ll jump in promptly,” said Berkshire's Vice Chairman. Ajit Jain was born in the year 1950 in India. Looking at Jain's early career milestones, he holds a ...

India's generics medicine industry is unlikely to be impacted by President Donald Trump's move to slash drug prices in the US drastically, said Sudarshan Jain, Secretary General, Indian Pharmaceutical ...

Indian-American advocate for the South Asian and AAPI community revealed that domestic visa renewal program had received a ...

Indian generic drugmakers typically operate on thin EBITDA margins of 5-15 percent on average for their base business in US, ...

India offers affordable education, but without job prospects, global students stay away. Here’s what must change to close the ...

Most Indian health, life and property insurance policies exclude war-related damages. Some global examples show why that need ...

Energy access is transforming rural healthcare but due to inadequate government policies, it remains a philanthropic ...

The Indian Pharmaceutical Alliance (IPA) emphasizes the need to balance innovation with affordability in response to ...

India's import restrictions on Bangladeshi goods, including readymade garments, may impact $770-800 million worth of annual ...

Trump's order to lower prescription drug prices in the US is unlikely to affect India's generic drug industry, experts say.

Iran and Turkey also offered mediation, though with mixed results. Iran’s offer was clouded by its fraught relationship with India, especially over India’s ties with Israel and Saudi Arabia. Turkey, ...